TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from IDT Australia Limited ( (AU:IDT) ) is now available.
IDT Australia Limited announced the cessation of 131,428 performance rights due to unmet conditions, effective February 28, 2025. This development may impact the company’s operational strategies and stakeholder interests, as it reflects on the company’s performance metrics and future incentive structures.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its expertise in drug formulation and production, serving both local and international markets.
YTD Price Performance: -9.09%
Average Trading Volume: 173,842
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$41.35M
Find detailed analytics on IDT stock on TipRanks’ Stock Analysis page.